Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

Radiation therapy can treat lung cancer at all stages, easing symptoms, improving precision and minimizing side effects with ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified ...

Data to be presented at ASCO reflect Boehringer's broad pipeline and growing body of evidence supporting innovative therapies for various ...

At 34, non-smoker Reyna Savage mistook persistent shoulder pain for a gym injury, only to be diagnosed with stage 4 non-small ...

Non-Small Cell Lung Cancer says. The clinical trial, which was announced as a breakthrough in 2022, is described as an “innovative alternative treatment for select patients,” by Northwestern ...

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung ... related symptoms. Instead, the symptoms often arise from a mix of site-specific ...

April 30 (Reuters) - (To receive the full newsletter in your inbox for free sign up here) An experimental Boehringer Ingelheim drug achieved “unprecedented” benefits in patients with an ...

The test processes whole-slide images of non-small cell lung cancer tissue to provide a quantitative TROP2 score, which Roche says provides a level of precision beyond manual methods. TROP2 has ...